Nicotine patches
Executive Summary
FDA's Drug Abuse Advisory Committee will address "pregnancy categories for nicotine-containing dosage units used for smoking cessation" at its July 14 meeting, agency announces in June 23 Federal Register. Recently-approved nicotine patches are currently pregnancy category D, carrying a warning against use in pregnant women who should be "encouraged to attempt cessation using educational and behavioral interventions before using pharmacological approaches." Marion Merrell Dow's Nicorette chewing gum is pregnancy category X, contraindicated in pregnant women. The meeting begins at 9 a.m. at the Holiday Inn Crowne Plaza in Rockville, Md.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth